Glycyrrhetinic acid modified MOFs for the treatment of liver cancer

Liver cancer remains a major cause of cancer-related death across the globe. Nano medicines have emerged as promising candidates to improve liver cancer chemotherapy. In this study, a glycyrrhetinic acid (GA) modified metal-organic framework-based drug delivery system (GA-MOFs) was developed to enha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanotechnology 2020-08, Vol.31 (32), p.325602-325602
Hauptverfasser: Li, Li, Han, Shasha, Yang, Chun, Liu, Lin, Zhao, Sengqun, Wang, Xiaofang, Liu, Bingmi, Pan, Hao, Liu, Yu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!